REFERENCE
Hoffmann-La Roche.Reports of bowel obstruction and gastrointestinal performation with RITUXAN (Rm) (rituximab). Company Communication: [3 pages], 10 Nov 2006. Available from: URL: http://www.hc-sc.gc.ca
Hoffman-La Roche.Reports of bowel obstruction and perforation with RITUXAN (Rm) (rituximab). Company Communication: [2 pages], 10 Nov 2006. Available from: URL: http://www.hc-sc.gc.ca
Rights and permissions
About this article
Cite this article
Roche warns about Rituxan-related intestinal obstruction/perforations. React. Wkly. 1128, 3 (2006). https://doi.org/10.2165/00128415-200611280-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200611280-00008